Stay updated on Rituximab Vs Azathioprine in Eosinophilic Granulomatosis Clinical Trial
Sign up to get notified when there's something new on the Rituximab Vs Azathioprine in Eosinophilic Granulomatosis Clinical Trial page.

Latest updates to the Rituximab Vs Azathioprine in Eosinophilic Granulomatosis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedLocations section updated to include Paris; outdated Paris Locations label and HHS Vulnerability Disclosure footer link removed; page revision bumped to v3.3.3.SummaryDifference0.2%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page.SummaryDifference0.1%

- Check48 days agoChange DetectedEditorial updates to the study listing, including a revised MAINRITSEG title/label and a new last update timestamp.SummaryDifference0.6%

- Check55 days agoChange DetectedRemoved a site-wide notice about government funding and potential delays; this does not affect the study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check69 days agoChange DetectedThe update appears to be administrative, including formatting tweaks and a newer last updated timestamp, with no changes to core study data such as eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check98 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference3%

Stay in the know with updates to Rituximab Vs Azathioprine in Eosinophilic Granulomatosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rituximab Vs Azathioprine in Eosinophilic Granulomatosis Clinical Trial page.